Showing results (321-330 of 479) with videos related to

Sort By:
Pageof 48
Italian Journal of Neurological Sciences|March 1, 1980
"Carnitine deficient" myopathy and cardiomyopathy with fatal outcomeF Cornelio, S Di Donato, D Testa, et al.
Archivio Per Le Scienze Mediche|April 1, 1979
[Immunological changes in diabetes mellitus. Study of lymphocyte populations]L Resegotti, G Palestro, M A Pistone, et al.
Molecular Psychiatry|February 13, 2002
In vitro biotransformation of the selective serotonin reuptake inhibitor citalopram, its enantiomers and demethylated metabolites by monoamine oxidase in rat and human brain preparationsM Kosel, C Gnerre, P Voirol, et al.
Journal of the American Chemical Society|October 25, 2001
Generalization of ionic partition diagrams to lipophilic compounds and to biphasic systems with variable phase volume ratiosV Gobry, S Ulmeanu, F Reymond, et al.
Acta Otorhinolaryngologica Italica : Organo Ufficiale Della Societa Italiana Di Otorinolaringologia E Chirurgia Cervico-Facciale|October 1, 1995
[The use of hearing aids in children with profound deafness. Methodology and results]G Tranchino, G Motta, A Covino, et al.
Drug Design and Delivery|December 1, 1987
Multivariate statistical analysis of L-dopa esters as potential anti-parkinsonian prodrugsH Van de Waterbeemd, B Testa, C Marrel, et al.
British Journal of Pharmacology|May 24, 2000
[(3)H]-trimetazidine mitochondrial binding sites: regulation by cations, effect of trimetazidine derivatives and other agents and interaction with an endogenous substanceD Morin, R Sapena, A Elimadi, et al.
The Journal of Pharmacy and Pharmacology|October 1, 1987
L-dopa esters as potential prodrugs: effect on brain concentration of dopamine metabolites in reserpinized miceD R Cooper, C Marrel, H van de Waterbeemd, et al.
British Journal of Pharmacology|May 14, 1998
Evidence for the existence of [3H]-trimetazidine binding sites involved in the regulation of the mitochondrial permeability transition poreD Morin, A Elimadi, R Sapena, et al.
The Journal of Pharmacy and Pharmacology|August 1, 1987
L-dopa esters as potential prodrugs: behavioural activity in experimental models of Parkinson's diseaseD R Cooper, C Marrel, H van de Waterbeemd, et al.
Pageof 48